Skip to main content

Treating prehypertension: medically sound and economically viable.

Publication ,  Journal Article
Kiely, AE; Kwatra, SG; Kwatra, MM
Published in: Blood Press
2009

The 7th Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure provided new guide-lines for the definition and management of hypertension. Notably, a new category-"prehypertension"-was created for intermediate systolic pressures exceeding 120 mmHg, the upper limit of normal, but less than 139 mmHg, the threshold for stage 1 hypertension. The therapeutic consequences of this new classification are not yet clear, but research indicates that prehypertension is an independent risk factor for cardiovascular, cognitive, and renal morbidities as well as diabetes, and statistical data indicate that prehypertension is present in over 30% of US, European, and Asian adults. However, while pharmacotherapy is recommended for hypertension, the use of drugs to control prehypertension is under question. Given the serious health consequences linked with prehypertension, such debates seem misplaced if patient well-being is our priority. While acknowledging the lack of specific randomized controlled trial data on this topic, we suggest that anti-hypertensive therapy be recommended for everyone with prehypertension and address resulting cost-benefit issues.

Duke Scholars

Published In

Blood Press

DOI

EISSN

1651-1999

Publication Date

2009

Volume

18

Issue

6

Start / End Page

300 / 303

Location

England

Related Subject Headings

  • Hypertension
  • Humans
  • Cardiovascular System & Hematology
  • Cardiovascular Diseases
  • Antihypertensive Agents
  • 3201 Cardiovascular medicine and haematology
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Kiely, A. E., Kwatra, S. G., & Kwatra, M. M. (2009). Treating prehypertension: medically sound and economically viable. Blood Press, 18(6), 300–303. https://doi.org/10.3109/08037050903444024
Kiely, Amanda Elisabeth, Shawn Gaurav Kwatra, and Madan Mohan Kwatra. “Treating prehypertension: medically sound and economically viable.Blood Press 18, no. 6 (2009): 300–303. https://doi.org/10.3109/08037050903444024.
Kiely AE, Kwatra SG, Kwatra MM. Treating prehypertension: medically sound and economically viable. Blood Press. 2009;18(6):300–3.
Kiely, Amanda Elisabeth, et al. “Treating prehypertension: medically sound and economically viable.Blood Press, vol. 18, no. 6, 2009, pp. 300–03. Pubmed, doi:10.3109/08037050903444024.
Kiely AE, Kwatra SG, Kwatra MM. Treating prehypertension: medically sound and economically viable. Blood Press. 2009;18(6):300–303.

Published In

Blood Press

DOI

EISSN

1651-1999

Publication Date

2009

Volume

18

Issue

6

Start / End Page

300 / 303

Location

England

Related Subject Headings

  • Hypertension
  • Humans
  • Cardiovascular System & Hematology
  • Cardiovascular Diseases
  • Antihypertensive Agents
  • 3201 Cardiovascular medicine and haematology
  • 1103 Clinical Sciences